This handout is for left main coronary artery (lmca) stemi-equivalent. Your care team identified this based on: avr st↑ ≥1 mm + diffuse st↓ ≥1 mm in ≥6 leads (lmca equivalent / 3-vessel disease).
Other reasons your team may use this plan: severe ischemic chest pain + hypotension/shock + lmca-equivalent ecg → emergent cath + mcs standby; known or newly identified lmca lesion on angio in acute coronary syndrome.
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| aspirin | 162-325 mg chewed | PO | load + 81 mg daily | ACC/AHA 2025 ACS Class I; same as parent; do NOT hold for CABG (continue peri-CABG per AHA 2025) |
| ticagrelor | 180 mg load → 90 mg BID — HOLD if CABG decided within 5 d; consider cangrelor bridge | PO | BID × 12 mo if PCI | PLATO PMID 19717846; ticagrelor washout 5 d before CABG required to mitigate bleeding (AHA 2025) |
| cangrelor | 30 mcg/kg IV bolus + 4 mcg/kg/min infusion | IV | bridge to oral P2Y12 or off for CABG | Short half-life IV P2Y12 — useful bridge if CABG decision pending or if cardiogenic shock with absent gut absorption |
| unfractionated heparin | 70-100 U/kg IV bolus then per ACT | IV | titrated | AHA 2025 Class I PCI anticoagulant; also required for Impella/ECMO MCS |
| metoprolol | DEFER until shock resolves and rhythm stable | PO | deferred | BB normally Class I post-MI, but AVOID/defer if SCAI B+ shock or hemodynamic instability; reintroduce only after shock resolution + ≥48h hemodynamic stability — encoded as contraindication_substitute (avoid in acute CS phenotype, restart in chronic management arm) |
Plan: LMCA STEMI-equivalent revascularization phenotype — adds to parent cardio.stemi.core.v1 reperfusion regimen with CABG-vs-PCI strategic axis + MCS bias
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
Cardiology + cardiac surgery follow-up; echo at 30-90 d for heart pumping strength (LVEF) + ICD eligibility (MADIT-II); cardiac rehab; advanced HF eval if EF <30 not recovering
Guideline: 2025 ACC/AHA ACS Guideline + ESC 2023 ACS + ESC/EACTS 2018 Revascularization + SYNTAX + EXCEL + DK-CRUSH